Publicacións nas que colabora con Manuel González Sagrado (125)

2019

  1. Acute calculous cholecystitis: a real-life management study in a tertiary teaching hospital

    Revista Española de Enfermedades Digestivas, Vol. 111, Núm. 9, pp. 667-671

2013

  1. Fatty acid-binding protein 2 Ala54Thr genotype is associated with insulin resistance and leptin levels changes after a high monounsaturated fat diet in obese non-diabetic patients

    Journal of Endocrinological Investigation, Vol. 36, Núm. 6, pp. 402-406

  2. Genetic variation in the cannabinoid receptor gene (CNR1) (G1359A polymorphism) and their influence on anthropometric parameters and metabolic parameters under a high monounsaturated vs. high polyunsaturated fat hypocaloric diets

    Journal of Nutritional Biochemistry, Vol. 24, Núm. 8, pp. 1431-1435

  3. Genetic variation in the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and their influence on weight loss and insulin resistance under a high monounsaturated fat hypocaloric diet

    Journal of Diabetes and its Complications, Vol. 27, Núm. 3, pp. 235-239

  4. Relation of the rs9939609 gene variant in FTO with metabolic syndrome in obese female patients

    Journal of Diabetes and its Complications, Vol. 27, Núm. 4, pp. 346-350

  5. Relation of visfatin to cardiovascular risk factors and adipocytokines in patients with impaired fasting glucose

    Nutrition, Vol. 29, Núm. 11-12, pp. 1300-1303

  6. Role of G308 promoter variant of tumor necrosis factor alpha gene on weight loss and metabolic parameters after a high monounsaturated versus a high polyunsaturated fat hypocaloric diets

    Medicina Clinica, Vol. 141, Núm. 5, pp. 189-193

  7. Role of insulin resistance and adipocytokines on serum alanine aminotransferase in obese patients with type 2 diabetes mellitus

    European Review for Medical and Pharmacological Sciences, Vol. 17, Núm. 15, pp. 2059-2064

  8. Role of the rs9939609 gene variant of FTO on cardiovascular risk factors and adipokines levels in naive patients with diabetes mellitus type 2

    International Journal of Diabetes in Developing Countries, Vol. 33, Núm. 4, pp. 202-206

  9. Serum visfatin levels and metabolic syndrome criteria in obese female subjects

    Diabetes/Metabolism Research and Reviews, Vol. 29, Núm. 7, pp. 576-581

  10. The rs9939609 gene variant in FTO modified the metabolic response of weight loss after a 3-month intervention with a hypocaloric diet

    Journal of Investigative Medicine, Vol. 61, Núm. 1, pp. 22-26